A Phase I Study of TQB728 Tablets on Tolerance and Pharmacokinetics

Clinical trial NCT04523285 · UNKNOWN

Trial details

NCT number: NCT04523285
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor or Hematologic Tumor

Start date: 2020-10-26
Primary completion: 2021-12-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.